The immune cell landscape in kidneys of patients with lupus nephritis

the Accelerating Medicines Partnership in SLE network

Research output: Contribution to journalArticlepeer-review

429 Scopus citations

Abstract

Lupus nephritis is a potentially fatal autoimmune disease for which the current treatment is ineffective and often toxic. To develop mechanistic hypotheses of disease, we analyzed kidney samples from patients with lupus nephritis and from healthy control subjects using single-cell RNA sequencing. Our analysis revealed 21 subsets of leukocytes active in disease, including multiple populations of myeloid cells, T cells, natural killer cells and B cells that demonstrated both pro-inflammatory responses and inflammation-resolving responses. We found evidence of local activation of B cells correlated with an age-associated B-cell signature and evidence of progressive stages of monocyte differentiation within the kidney. A clear interferon response was observed in most cells. Two chemokine receptors, CXCR4 and CX3CR1, were broadly expressed, implying a potentially central role in cell trafficking. Gene expression of immune cells in urine and kidney was highly correlated, which would suggest that urine might serve as a surrogate for kidney biopsies.

Original languageEnglish (US)
Pages (from-to)902-914
Number of pages13
JournalNature Immunology
Volume20
Issue number7
DOIs
StatePublished - Jul 1 2019

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'The immune cell landscape in kidneys of patients with lupus nephritis'. Together they form a unique fingerprint.

Cite this